News Releases
- September 13, 2022Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington's Disease and Prion Diseases
- September 8, 2022Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders
- August 29, 2022Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer
Media Coverage
Events & Presentations
-
Annovis R&D Day Webcast View Webcast
-
Annovis Corporate Presentation - February 2024
-
AD-PD Conference - March 2022
Filings
Filings
Description
Date Filed
Available Formats
E-mail Alerts
Back to Top